Clinical Trial

EKO SENSORA: Detecting Clinically Significant Murmurs

Study acronym: EkoNM
Recruiting
View on ClinicalTrials.gov →
Summary
The Eko Artificial Intelligence (AI) has primarily been evaluated in the primary care setting. The digital stethoscope records a phonocardiogram of heart sounds of the patient and uses machine learning artificial intelligence to identify if there are abnormalities present (Eko Health, 2023). The Eko SENSORA will be tested in the emergency department. Chest pain, fatigue, shortness of breath and syncope are all symptoms that could indicate a cardiac dysfunction. The hypothesis is that this device will allow us increased ability to detect valvular heart disease that is clinically significant.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-11-30; most recent amendment 2026-07-17.
Trial Details
NCT Number NCT06155643
Lead Sponsor Corewell Health South
Conditions Heart Murmurs
Enrollment 300 participants
Start Date 2023-10-26
Primary Completion 2027-07-26 (estimated)
Study Completion 2027-07-26 (estimated)
Updated on ClinicalTrials.gov 2026-07-20